Bioventus Inc. ( BVS) - Key Metrics
BVS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $2.37 | $0.22 | $0.57 | $0.56 |
| 2025Q3 | $2.07 | $0.05 | $0.45 | $0.44 |
| 2025Q2 | $2.22 | $0.11 | $0.39 | $0.38 |
| 2025Q1 | $1.88 | -$0.04 | -$0.29 | -$0.31 |
BVS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 8.40 |
| 2025Q3 | ? | 35.32 |
| 2025Q2 | ? | 15.09 |
| 2025Q1 | ? | -56.51 |
BVS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 1.39% | ? |
| 2025Q4 | 7.54% | ? |
| 2025Q3 | 6.65% | ? |
| 2025Q2 | 5.61% | ? |
| 2025Q1 | -3.38% | ? |
BVS
Price: $11.80
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.41 USD
P/E Ratio: 24.85
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 710.0 million